Loading company details...
Beta
Latest Form 4 (Sep 9, 2026): MPM BIOVENTURES 2018, L.P. (10% Owner): Sale of 38,500 shares, $273.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | MPM BIOVENTURES 2018, L.P. | Sale | 38,500 | $273.7K |
| Sep 9, 2026 | MPM BioVentures 2014, L.P. | Sale | 38,500 | $273.7K |
| Sep 3, 2026 | MPM BIOVENTURES 2018, L.P. | Sale | 29,088 | $205.4K |
| Sep 3, 2026 | MPM BioVentures 2014, L.P. | Sale | 29,088 | $205.4K |
| Sep 3, 2026 | Dipal Doshi, CEO | Tax Withholding | 8,724 | $62.3K |
| Sep 3, 2026 | Nathan J. Dowden, President & COO | Tax Withholding | 2,528 | $18.1K |
| Sep 3, 2026 | Natarajan Sethuraman, President, Research & Develop. | Tax Withholding | 2,079 | $14.9K |
| Sep 3, 2026 | Kory James Wentworth, Chief Financial Officer | Tax Withholding | 1,733 | $12.4K |
| Aug 31, 2026 | MPM BIOVENTURES 2018, L.P. | Sale | 38,922 | $280.2K |
| Aug 31, 2026 | MPM BioVentures 2014, L.P. | Sale | 38,922 | $280.2K |